MARKET

SNCA

SNCA

Seneca Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.450
+0.110
+8.21%
Closed 17:16 03/01 EST
OPEN
1.360
PREV CLOSE
1.340
HIGH
1.500
LOW
1.360
VOLUME
630.73K
TURNOVER
--
52 WEEK HIGH
2.200
52 WEEK LOW
0.5000
MARKET CAP
25.08M
P/E (TTM)
-0.8840
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PTVCA, AEGN, CATM, CHNG, GWPH, PS, SNCA
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PR Newswire · 02/17 18:21
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16)
Benzinga · 02/17 12:26
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - GWPH, VIE, FLIR, SNCA
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PR Newswire · 02/04 11:51
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - GWPH, VIE, FLIR, SNCA
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
PR Newswire · 02/04 11:51
BRIEF-Seneca Biopharma Regains Compliance With Nasdaq Listing Requirements
reuters.com · 01/25 13:20
Seneca Biopharma Regains Compliance With NASDAQ Listing Requirements
GERMANTOWN, Md., Jan. 25, 2021 /PRNewswire/ -- Seneca Biopharma, Inc, (NASDAQ:SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today
Benzinga · 01/25 13:04
Seneca Biopharma Regains Compliance with NASDAQ Listing Requirements
Seneca Biopharma, Inc, (NASDAQ:SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on January 22, 2021 indicati...
PR Newswire · 01/25 13:00
Seneca Biopharma Regains Compliance with NASDAQ Listing Requirements
PR Newswire · 01/25 13:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SNCA. Analyze the recent business situations of Seneca Biopharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Price Target
The average SNCA stock price target is 26.00 with a high estimate of 26.00 and a low estimate of 26.00.
EPS
Institutional Holdings
Institutions: 43
Institutional Holdings: 583.16K
% Owned: 3.37%
Shares Outstanding: 17.30M
TypeInstitutionsShares
Increased
6
128.78K
New
5
-338.00K
Decreased
3
143.50K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.13%
Pharmaceuticals & Medical Research
+1.38%
Key Executives
Chairman/Chief Executive Officer/Executive Director
Kenneth Carter
President/Chief Operating Officer
Matthew Kalnik
Other
David Recker
Chief Financial Officer/Chief Accounting Officer
Dane Saglio
Director
Mary Gray
Director
David Mazzo
Independent Director
Cristina Csimma
Independent Director
Scott Ogilvie
Independent Director
Sandford Smith
Independent Director
Binxian Wei
Independent Director
Stanley Westreich
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About SNCA
Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is focused on finding and acquiring new assets, sciences and technologies that provide therapies for patients. It intends to focus on developing a pipeline of biopharmaceuticals and commercializing those products.

Webull offers kinds of Seneca Biopharma Inc stock information, including NASDAQ:SNCA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNCA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNCA stock methods without spending real money on the virtual paper trading platform.